Annual Drug Patent Expirations for AKLIEF
Aklief is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has forty-two patent family members in twenty-six countries.
The generic ingredient in AKLIEF is trifarotene. One supplier is listed for this compound. Additional details are available on the trifarotene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
